Biohaven Pharmaceutical Holding Company Ltd.

DB:2VN 주식 보고서

시가총액: €11.0b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Biohaven Pharmaceutical Holding 관리

관리 기준 확인 2/4

주요 정보

Vlad Coric

최고 경영자

US$10.9m

총 보상

CEO 급여 비율6.9%
CEO 임기7yrs
CEO 소유권1.3%
경영진 평균 재임 기간3.5yrs
이사회 평균 재임 기간4yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Vlad Coric 의 보수는 Biohaven Pharmaceutical Holding 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2022n/an/a

-US$1b

Mar 31 2022n/an/a

-US$791m

Dec 31 2021US$11mUS$750k

-US$847m

Sep 30 2021n/an/a

-US$865m

Jun 30 2021n/an/a

-US$889m

Mar 31 2021n/an/a

-US$859m

Dec 31 2020US$1mUS$622k

-US$767m

Sep 30 2020n/an/a

-US$698m

Jun 30 2020n/an/a

-US$609m

Mar 31 2020n/an/a

-US$639m

Dec 31 2019US$7mUS$550k

-US$529m

Sep 30 2019n/an/a

-US$434m

Jun 30 2019n/an/a

-US$390m

Mar 31 2019n/an/a

-US$218m

Dec 31 2018US$5mUS$500k

-US$241m

Sep 30 2018n/an/a

-US$213m

Jun 30 2018n/an/a

-US$195m

Mar 31 2018n/an/a

-US$202m

Dec 31 2017US$4mUS$421k

-US$139m

Sep 30 2017n/an/a

-US$138m

Jun 30 2017n/an/a

-US$123m

Mar 31 2017n/an/a

-US$83m

Dec 31 2016US$784kUS$350k

-US$64m

보상 대 시장: Vlad's total compensation ($USD10.92M) is above average for companies of similar size in the German market ($USD5.34M).

보상과 수익: Vlad's compensation has increased whilst the company is unprofitable.

CEO

Vlad Coric (51 yo)

7yrs

테뉴어

US$10,924,824

보상

Dr. Vladimir Coric, also known as Vlad, M.D., is Director at Pyramid Biosciences Inc. since August 2020. He has been Independent Director of Social Capital Suvretta Holdings Corp. I since June 29, 2021. He...

리더십 팀

이름위치테뉴어보상소유권
Vladimir Coric
Chairman of the Board7yrsUS$10.92m1.29%
$ 141.8m
Matthew Buten
Chief Financial Officerless than a yearUS$6.03m0.0086%
$ 949.2k
Kimberly Gentile
Senior Vice President of Clinical Operations5.8yrsUS$3.76m0.016%
$ 1.8m
Elyse Stock
Chief Medical Officer5.3yrsUS$3.88m0.023%
$ 2.5m
William Jones
Chief Commercial Officer of Migraine & Common Diseases3.5yrsUS$4.69m0.020%
$ 2.2m
Matthew DeLawder
Director of Accounting3.8yrs데이터 없음데이터 없음
George Clark
VP & Chief Accounting Officer1.2yrs데이터 없음0.0057%
$ 625.1k
Charles Conway
Chief Scientific Officer5.8yrsUS$2.79m0%
$ 0
Wendy Goss
Executive Administrative Assistantno data데이터 없음데이터 없음
Clifford Bechtold
President & GM of Biohaven Ireland and Chief Compliance Officer1.4yrs데이터 없음데이터 없음
Warren Volles
General Counsel & Chief Legal Officerless than a year데이터 없음데이터 없음
Jenny Strauss
Manager of Medical Information & Communication2.8yrs데이터 없음데이터 없음

3.5yrs

평균 재임 기간

58yo

평균 연령

경험이 풍부한 관리: 2VN's management team is considered experienced (3.5 years average tenure).

이사회 구성원

이름위치테뉴어보상소유권
Vladimir Coric
Chairman of the Board7yrsUS$10.92m1.29%
$ 141.8m
Douglas Gray
Corporate Secretary & Directorless than a year데이터 없음데이터 없음
John Childs
Independent Director8.8yrsUS$560.01k4.25%
$ 466.4m
Julia Gregory
Independent Director5.2yrsUS$560.06k0%
$ 0
Robert Hugin
Independent Director2.3yrsUS$990.02k0.0041%
$ 446.0k
Gregory Bailey
Independent Director8.8yrsUS$541.83k3.61%
$ 397.0m
Michael Heffernan
Lead Independent Director2.8yrsUS$987.80k0.041%
$ 4.5m
Maurizio Fava
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Richard B. Lipton
Chairman of Scientific Advisory Boardno data데이터 없음데이터 없음
John Krystal
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Kishan Mehta
Director1.3yrsUS$741.91k0.015%
$ 1.6m
Gerard Sanacora
Member of Scientific Advisory Boardno data데이터 없음데이터 없음

4.0yrs

평균 재임 기간

66yo

평균 연령

경험이 풍부한 이사회: 2VN's board of directors are considered experienced (4 years average tenure).